Fulminant tumefactive multiple sclerosis: therapeutic implications of histopathology.
Haupts
Michael R
MR
Schimrigk
Sebastian K
SK
Brune
Nils
N
Chan
Andrew
A
Ahle
Guido
G
Hellwig
Kerstin
K
König
Fatima B
FB
Schlegel
Uwe
U
Brück
Wolfgang
W
Gold
Ralf
R
D000328:Adult; D018826:CD13 Antigens / Q000378:metabolism; D040502:Calgranulin B / Q000378:metabolism; D003711:Demyelinating Diseases / Q000209:etiology* / Q000473:pathology*; D005260:Female; D006801:Humans; D008264:Macrophages / Q000378:metabolism / Q000473:pathology; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000150:complications* / Q000473:pathology* / Q000628:therapy; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein / Q000378:metabolism; D063308:Myelin-Oligodendrocyte Glycoprotein
D040502:Calgranulin B; C571326:MOG protein, human; D009185:Myelin Proteins; D018992:Myelin-Associated Glycoprotein; D063308:Myelin-Oligodendrocyte Glycoprotein; D018826:CD13 Antigens